These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10392362)

  • 1. The effect of growth hormone treatment on stature in Aarskog syndrome.
    Petryk A; Richton S; Sy JP; Blethen SL
    J Pediatr Endocrinol Metab; 1999; 12(2):161-5. PubMed ID: 10392362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone treatment in Aarskog syndrome: analysis of the KIGS (Pharmacia International Growth Database) data.
    Darendeliler F; Larsson P; Neyzi O; Price AD; Hagenäs L; Sipilä I; Lindgren AC; Otten B; Bakker B;
    J Pediatr Endocrinol Metab; 2003; 16(8):1137-42. PubMed ID: 14594174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional delay influences the auxological response to growth hormone treatment in children with short stature and growth hormone sufficiency.
    Gunn KC; Cutfield WS; Hofman PL; Jefferies CA; Albert BB; Gunn AJ
    Sci Rep; 2014 Aug; 4():6061. PubMed ID: 25317732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth response, near-adult height, and patterns of growth and puberty in patients with noonan syndrome treated with growth hormone.
    Romano AA; Dana K; Bakker B; Davis DA; Hunold JJ; Jacobs J; Lippe B
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2338-44. PubMed ID: 19401366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
    Kemp SF; Kuntze J; Attie KM; Maneatis T; Butler S; Frane J; Lippe B
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5247-53. PubMed ID: 15998780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone therapy in Turner's syndrome. Impact of injection frequency and initial bone age.
    Rongen-Westerlaken C; van Es A; Wit JM; Otten BJ; De Muinck Keizer-Schrama SM; Drayer NM; Oostdijk W; Delemarre-vd Waal HA; Gons MH; Waelkens JJ
    Am J Dis Child; 1992 Jul; 146(7):817-20. PubMed ID: 1496949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment of girls with Turner syndrome: the National Cooperative Growth Study experience.
    Plotnick L; Attie KM; Blethen SL; Sy JP
    Pediatrics; 1998 Aug; 102(2 Pt 3):479-81. PubMed ID: 9685447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy.
    Hopwood NJ; Hintz RL; Gertner JM; Attie KM; Johanson AJ; Baptista J; Kuntze J; Blizzard RM; Cara JF; Chernausek SD
    J Pediatr; 1993 Aug; 123(2):215-22. PubMed ID: 8345416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: the National Cooperative Growth Study experience.
    Chernausek SD; Breen TJ; Frank GR
    J Pediatr; 1996 May; 128(5 Pt 2):S22-7. PubMed ID: 8627464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment with biosynthetic growth hormone (GH) of familial short stature].
    Farello G; De Simone M; Gentile T; De Matteis F
    Minerva Pediatr; 1994; 46(7-8):347-50. PubMed ID: 7935253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone treatment in Noonan syndrome.
    Tanaka T
    Acta Paediatr Jpn; 1996 Feb; 38(1):99-101. PubMed ID: 8992871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Turner syndrome: a virtually certain indication for growth hormone treatment].
    Rongen-Westerlaken C; Wit JM
    Tijdschr Kindergeneeskd; 1992 Oct; 60(5):155-63. PubMed ID: 1448805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia.
    Quintos JB; Vogiatzi MG; Harbison MD; New MI
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1511-7. PubMed ID: 11297576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment of children with myelomeningocele.
    Rotenstein D; Breen TJ
    J Pediatr; 1996 May; 128(5 Pt 2):S28-31. PubMed ID: 8627465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The short-term effects of growth hormone therapy on height velocity and cardiac ventricular wall thickness in children with Noonan's syndrome.
    Cotterill AM; McKenna WJ; Brady AF; Sharland M; Elsawi M; Yamada M; Camacho-Hübner C; Kelnar CJ; Dunger DB; Patton MA; Savage MO
    J Clin Endocrinol Metab; 1996 Jun; 81(6):2291-7. PubMed ID: 8964866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized Trial of Aromatase Inhibitors, Growth Hormone, or Combination in Pubertal Boys with Idiopathic, Short Stature.
    Mauras N; Ross JL; Gagliardi P; Yu YM; Hossain J; Permuy J; Damaso L; Merinbaum D; Singh RJ; Gaete X; Mericq V
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4984-4993. PubMed ID: 27710241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.